DISEASE PROGRESSION

Clinical trials for DISEASE PROGRESSION explained in plain language.

Never miss a new study

Get alerted when new DISEASE PROGRESSION trials appear

Sign up with your email to follow new studies for DISEASE PROGRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New hope for liver cancer patients with liver damage: drug tested after immunotherapy fails

Disease control Not yet recruiting

This phase 2 trial tests the cancer pill regorafenib in 20 adults with advanced liver cancer and moderate liver dysfunction (Child-Pugh B) whose disease worsened after first-line immunotherapy. Participants take regorafenib daily for 3 weeks on, 1 week off, until the cancer progr…

Matched conditions: DISEASE PROGRESSION

Phase: PHASE2 • Sponsor: Ju Hyun Shim • Aim: Disease control

Last updated Jun 27, 2026 12:04 UTC

DISEASE PROGRESSION

Get alerted when new DISEASE PROGRESSION trials appear

New hope for liver cancer patients with liver damage: drug tested after immunotherapy fails